Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

Opinion & Analysis (CSE:BNXT)

XPhyto: Buyouts, Biosensors and a Booming Business

Marc Davis August 4, 2021

XPhyto: Proof of Concept for Mescalin Synthesis

Marc Davis June 10, 2021

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

Marc Davis June 3, 2021

A Life Sciences Project Accelerator Kicks into High Gear

Marc Davis May 11, 2021

XPhyto: Why Rapid PCR Testing is Here to Stay

Marc Davis April 23, 2021

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

Marc Davis April 6, 2021

XPhyto: Readying a Next-Generation PCR Test Kit for Marquis Sales Opportunities

Marc Davis March 30, 2021

PCR Testing: XPhyto Disrupts a Blockbuster Business

Marc Davis February 25, 2021

XPhyto: Innovating a Therapeutic Psychedelic Drug Pipeline

Marc Davis January 20, 2021

XPhyto Announces a PCR Testing Breakthrough

Marc Davis December 17, 2020

XPhyto to Announce PCR Test Kit Final Validation Results

Marc Davis November 26, 2020

Covid 19: Will pain-free, at-home screening tests be our salvation?

Marc Davis September 1, 2020

Bayer, Siltronic, XPhyto - is it worthwhile to invest now?

Mario Hose August 25, 2020

Comparing COVID-19 Test Kits: Sona vs XPhyto

Marc Davis July 23, 2020

BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

Mario Hose July 15, 2020

Gilead, Teva, XPhyto - Global marketing potential

Mario Hose June 16, 2020

Aurora, Bayer, XPhyto - scalable growth markets with potential

Mario Hose June 8, 2020

BioNTech, Evotec, XPhyto - will the next rally start?

Mario Hose May 26, 2020

The Golden Bullet for Drug Delivery

Marc Davis May 14, 2020

XPhyto: The Cutting Edge of Medical Cannabis Science

Marc Davis May 14, 2020